ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FE02 | BioTech | Panitumumab - 100mg/5ml | 7238 | 187459/13 | VECTIBIX | 100mg/5ml | 1 x 5ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | 40,364,800 L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
L01FE02 | BioTech | Panitumumab - 100mg/5ml | 7238/388 | 187459/13 | VECTIBIX | 100mg/5ml | 1 x 5ml | Injectable concentrated solution | Infusion | Mersaco | Amgen Europe BV | The Netherlands | L.L | 10.71 | E1 | Amgen Europe BV | The Netherlands | 2/5/2024 |